JPWO2022256359A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022256359A5
JPWO2022256359A5 JP2023573384A JP2023573384A JPWO2022256359A5 JP WO2022256359 A5 JPWO2022256359 A5 JP WO2022256359A5 JP 2023573384 A JP2023573384 A JP 2023573384A JP 2023573384 A JP2023573384 A JP 2023573384A JP WO2022256359 A5 JPWO2022256359 A5 JP WO2022256359A5
Authority
JP
Japan
Prior art keywords
seq
mtorr
holding
buffer
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023573384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521329A5 (https=
JP2024521329A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031694 external-priority patent/WO2022256359A1/en
Publication of JP2024521329A publication Critical patent/JP2024521329A/ja
Publication of JP2024521329A5 publication Critical patent/JP2024521329A5/ja
Publication of JPWO2022256359A5 publication Critical patent/JPWO2022256359A5/ja
Pending legal-status Critical Current

Links

JP2023573384A 2021-06-01 2022-06-01 凍結乾燥タンパク質製剤を製造する迅速な方法 Pending JP2024521329A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163195265P 2021-06-01 2021-06-01
US63/195,265 2021-06-01
PCT/US2022/031694 WO2022256359A1 (en) 2021-06-01 2022-06-01 Accelerated method of making lyophilized protein formualtions

Publications (3)

Publication Number Publication Date
JP2024521329A JP2024521329A (ja) 2024-05-31
JP2024521329A5 JP2024521329A5 (https=) 2025-06-09
JPWO2022256359A5 true JPWO2022256359A5 (https=) 2025-06-09

Family

ID=82100125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023573384A Pending JP2024521329A (ja) 2021-06-01 2022-06-01 凍結乾燥タンパク質製剤を製造する迅速な方法

Country Status (14)

Country Link
US (1) US20240368254A1 (https=)
EP (1) EP4346778A1 (https=)
JP (1) JP2024521329A (https=)
KR (1) KR20240016260A (https=)
CN (1) CN117241787A (https=)
AR (1) AR126044A1 (https=)
AU (1) AU2022285665A1 (https=)
BR (1) BR112023024757A2 (https=)
CA (1) CA3217210A1 (https=)
CL (1) CL2023003443A1 (https=)
IL (1) IL307677A (https=)
MX (1) MX2023014034A (https=)
TW (1) TW202313108A (https=)
WO (1) WO2022256359A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4553432B1 (en) 2023-11-08 2026-04-29 Bachem Holding AG Drying bag and drying system
WO2025099273A1 (en) 2023-11-08 2025-05-15 Bachem Holding Ag Drying bag and drying system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
ATE243754T1 (de) 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
EP1299419A2 (en) 2000-05-24 2003-04-09 Imclone Systems, Inc. Bispecific immunoglobulin-like antigen binding proteins and method of production
JP2008512352A (ja) 2004-07-17 2008-04-24 イムクローン システムズ インコーポレイティド 新規な四価の二重特異性抗体
CA2697922A1 (en) 2007-08-28 2009-03-12 Biogen Idec Ma Inc. Compositions that bind multiple epitopes of igf-1r
IL272513B2 (en) * 2017-09-15 2023-04-01 Amgen Inc Lyophilization process for pharmaceutical formulation of medical protein
AU2021330845A1 (en) * 2020-08-24 2023-01-19 Amgen Inc. Pharmaceutical formulation comprising a bite, bispecific antibody, and methionine
KR20230067632A (ko) * 2020-09-14 2023-05-16 암젠 인크 동결건조된 단백질 제형의 제조 방법

Similar Documents

Publication Publication Date Title
CN102712677B (zh) 脂肽组合物和相关方法
EP2485766B1 (fr) Excipient stabilisant pour vaccins a virus entiers inactifs
US20250242010A1 (en) Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
US8795686B2 (en) Stable, dried rotavirus vaccine, compositions and process for preparation thereof
US20050074449A1 (en) Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
US12251474B2 (en) Process for lyophilized pharmaceutical formulations of a therapeutic protein
EP2143440A1 (fr) Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
JP2021512881A5 (https=)
WO1992015331A1 (en) Lyophilized monoclonal antibody preparation
CN103492407A (zh) 冻干制剂
JP2021521119A5 (https=)
US20090208509A1 (en) Pharmaceutical formulation of an antibody against IL-1R
CN114286690A (zh) 稳定的低粘度抗体配制品及其用途
BE1025187A1 (fr) Nouvelle formulation
US20210338586A1 (en) Stable lyophilized dosage form of protein
JPWO2022256359A5 (https=)
JP7085482B2 (ja) スタフィロコッカス感染症のための凍結乾燥製剤を製造する方法
JPWO2022046651A5 (https=)
JPWO2022038281A5 (https=)
JPWO2021222355A5 (https=)
US20250312436A1 (en) Stabilization of virus-based therapeutic agent
JPH0341032A (ja) モチリン類含有水溶液
JPWO2021222347A5 (https=)
JPWO2022132636A5 (https=)
JPWO2023018870A5 (https=)